Sébastien Colette joined GSK Vaccines in 2013, in the Cell and Viral Drug Substance team of the Technical Research and Development Department. He is focusing on upstream process development (viral- and recombinant protein-based production processes), optimization, and intensification at different development phases (early and late projects, process transfer to commercial facilities, life cycle projects). Sébastien holds a Master in Biomedical Sciences and a PhD in Biomedical and Pharmaceutical Sciences from University Catholique of Louvain, Brussels, Belgium (PhD devoted to the study of chronic gynecological inflammatory and estrogen-dependent disease: endometriosis).